ストックスクリーナーアプリを入手
1.30
0.78%
0.01
アフターアワーズ：
1.30
前日終値:
$1.29
開ける：
$1.29
24時間の取引高:
351.84K
Relative Volume:
0.61
時価総額：
$47.57M
収益：
$2.91M
当期純損益:
$-220.40M
株価収益率:
-0.3571
EPS:
-3.64
ネットキャッシュフロー:
$-176.15M
1週間 パフォーマンス:
+1.56%
1か月 パフォーマンス:
-4.41%
6か月 パフォーマンス:
-5.80%
1年 パフォーマンス:
-85.28%
1日の値動き範囲:
$1.27
$1.31
1週間の範囲:
$1.27
$1.31
52週間の値動き範囲:
$0.92
$22.50
Igm Biosciences Inc Stock (IGMS) Company Profile
名前
Igm Biosciences Inc
セクター
電話
650-965-7873
住所
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
IGMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
1.30 | 76.57M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2025-01-10 | ダウングレード | Guggenheim | Buy → Neutral |
| 2025-01-10 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-10 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-10 | ダウングレード | Stifel | Buy → Hold |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-10-01 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2024-10-01 | ダウングレード | Truist | Buy → Hold |
| 2024-02-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-12-07 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-11-09 | 再開されました | Jefferies | Buy |
| 2022-10-17 | 開始されました | JP Morgan | Neutral |
| 2022-08-29 | 開始されました | BofA Securities | Buy |
| 2021-12-13 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-11-05 | アップグレード | Wedbush | Neutral → Outperform |
| 2021-08-26 | 開始されました | Morgan Stanley | Overweight |
| 2021-01-29 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-01-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-22 | ダウングレード | Wedbush | Outperform → Neutral |
| 2020-07-17 | 開始されました | Robert W. Baird | Outperform |
| 2020-07-01 | 開始されました | H.C. Wainwright | Buy |
| 2020-05-28 | 開始されました | SunTrust | Buy |
| 2020-04-22 | 開始されました | Wedbush | Outperform |
| 2019-10-14 | 開始されました | Guggenheim | Buy |
| 2019-10-14 | 開始されました | Jefferies | Buy |
| 2019-10-14 | 開始されました | Piper Jaffray | Overweight |
| 2019-10-14 | 開始されました | Stifel | Buy |
すべてを表示
Igm Biosciences Inc (IGMS) 最新ニュース
IGM Biosciences Inc.’s Beta Climbs After Market VolatilityProven Entry Plan With Low Risk Shared - beatles.ru
Is IGM Biosciences Inc. stock a hidden gemPotential 10x Return Stocks - sisaissue.com
IGM Biosciences (IGMS) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Is IGM Biosciences Inc. stock a top performer YTDGolden Triangle Formation Screener - thegnnews.com
IGM Biosciences earnings beat by $1.70, revenue topped estimates - Investing.com Canada
IGM Biosciences (NASDAQ:IGMS) Releases Quarterly Earnings Results, Beats Estimates By $1.88 EPS - MarketBeat
What are analysts’ price targets for IGM Biosciences Inc. in the next 12 monthsGet exclusive market insights for better trading - Jammu Links News
How strong is IGM Biosciences Inc. company’s balance sheetUnlock exclusive trading strategies - Jammu Links News
Is IGM Biosciences Inc. a good long term investmentGet exclusive access to expert stock recommendations - Jammu Links News
How does IGM Biosciences Inc. compare to its industry peersMaximize portfolio value with timely trades - Jammu Links News
Is it the right time to buy IGM Biosciences Inc. stockMaximize gains with expert analysis - Jammu Links News
When is IGM Biosciences Inc. stock expected to show significant growthFind market-beating stocks for your portfolio - Jammu Links News
What is the risk reward ratio of investing in IGM Biosciences Inc. stockBuild a diversified portfolio for sustainable growth - Jammu Links News
What catalysts could drive IGM Biosciences Inc. stock higher in 2025Access daily stock market expert updates - Jammu Links News
How many analysts rate IGM Biosciences Inc. as a “Buy”Get timely alerts on top-performing stocks - Jammu Links News
Chart based exit strategy for IGM Biosciences Inc.High Probability Trade Outcome Prediction - Newser
Sentiment Tools Show Shift in Trader Mood on IGM Biosciences Inc.Earnings Play Trade Plan With Alerts Shared - metal.it
IGM Biosciences 2025 Q2 Earnings Strong Performance as Net Income Swings 303.7% - AInvest
Is IGM Biosciences Inc. a candidate for recovery playScalable Strategy with Chart Confirmation - Newser
Custom watchlist performance reports with IGM Biosciences Inc.High Return Trade Roadmap with Setup Filters - Newser
IGM Biosciences Q2 2025 Earnings Report: Persistent Losses Amid Weak Earnings Beat Performance - AInvest
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates - sharewise.com
IGM Biosciences Surpasses Earnings and Revenue Estimates in Q2, Shares Down 79.4% YTD - AInvest
How does IGM Biosciences Inc. generate profit in a changing economyFree Stock Alerts For Every Investor - Jammu Links News
IGM Biosciences Q2 2025 Earnings Miss: A Harbinger of Persistent Pressure - AInvest
IGM Biosciences Inc. stock daily chart insightsAlpha Stock Picks with Chart Confirmation - Newser
Competitive Positioning of IGM Biosciences Inc.: Is It Leading or LaggingFree Oversold Bounce Stock Play Ideas - Newser
Why IGM Biosciences Inc. stock attracts strong analyst attentionFree Consistent Income Focused Trade List - Newser
Multi factor analysis applied to IGM Biosciences Inc.Predictable Return Plan with Entry Guidance - Newser
Key metrics from IGM Biosciences Inc.’s quarterly dataShort-Term Trade Setup with Forecast Insight - Newser
Volume spikes in IGM Biosciences Inc. stock – what they meanFree Low Risk Picks for Daily Trading - Newser
Predicting IGM Biosciences Inc. trend using moving averagesDeep Learning Stock Forecast for Investors - Newser
Mary Beth Harler Sells 14,501 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) Stock - MarketBeat
What makes IGM Biosciences Inc. stock price move sharplyFree Accurate Technical Trend Reversal Picks - Newser
Insider Selling: IGM Biosciences, Inc. (NASDAQ:IGMS) CFO Sells 8,741 Shares of Stock - MarketBeat
Will IGM Biosciences Inc. Recover After Recent DeclineCapital Growth With Controlled Risk Picks Suggested - metal.it
Is IGM Biosciences Inc. a growth stock or a value stockCapitalize on market trends with confidence - jammulinksnews.com
Order flow analysis tools used on IGM Biosciences Inc. Free Trade Setups With Clear Risk Limits - Newser
Igm Biosciences Inc (IGMS) 財務データ
収益
当期純利益
現金流量
EPS
Igm Biosciences Inc (IGMS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Harler Mary Beth | Chief Executive Officer |
Jul 23 '25 |
Sale |
1.27 |
14,501 |
18,457 |
323,680 |
| Decker Lisa Lynn | CHIEF BUSINESS OFFICER |
Jul 23 '25 |
Sale |
1.27 |
4,409 |
5,612 |
68,169 |
| Weber Steven | PRINCIPAL ACCOUNTING OFFICER |
Jun 16 '25 |
Sale |
1.20 |
486 |
583 |
26,530 |
| Tahir Misbah | CHIEF FINANCIAL OFFICER |
Jun 16 '25 |
Sale |
1.20 |
1,522 |
1,825 |
178,802 |
| Harler Mary Beth | Chief Executive Officer |
Jun 16 '25 |
Sale |
1.20 |
1,522 |
1,825 |
338,181 |
| Decker Lisa Lynn | CHIEF BUSINESS OFFICER |
Jun 16 '25 |
Sale |
1.20 |
951 |
1,140 |
72,578 |
| Weber Steven | PRINCIPAL ACCOUNTING OFFICER |
May 14 '25 |
Sale |
1.12 |
1,865 |
2,090 |
27,016 |
| Weber Steven | PRINCIPAL ACCOUNTING OFFICER |
Mar 14 '25 |
Sale |
1.23 |
1,701 |
2,092 |
28,881 |
| Tahir Misbah | CHIEF FINANCIAL OFFICER |
Mar 14 '25 |
Sale |
1.23 |
7,329 |
9,015 |
180,324 |
| Harler Mary Beth | Chief Executive Officer |
Mar 14 '25 |
Sale |
1.23 |
7,329 |
9,015 |
339,703 |
0.91%
3.06%
大文字化:
|
ボリューム (24 時間):